Oxford Immunotec Stock Price, News & Analysis

OXFD NASDAQ

Company Description

Oxford Immunotec (NASDAQ: OXFD) is a publicly traded surgical and medical instrument manufacturing company in the Manufacturing sector.

OXFD stock has gained 64.8% over the past year.

This page provides a comprehensive overview of OXFD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+64.84%

Performance 1 year

$0.0

Market Cap

25.6M

Shares outstanding

Oxford Immunotec (OXFD) stock. Over the past 12 months, the stock has gained 64.8%.

Latest News

View All

March 4, 2021

+0.05%

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection

fda approval covid-19

February 8, 2021

-0.27%

Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. – South Korea) to Market the T-SPOT® Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea

February 4, 2021

0.00%

Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemic Coronaviruses

January 14, 2021

-0.23%

New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19

covid-19

January 13, 2021

-0.90%

Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study

clinical trial covid-19

January 7, 2021

+26.52%

PerkinElmer to Acquire Oxford Immunotec Global PLC

acquisition

Oxford Immunotec has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include fda approval, covid-19, clinical trial, acquisition. View all OXFD news →

SEC Filings

View All

No SEC filings available for OXFD.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

OXFD Company Profile & Sector Positioning

Oxford Immunotec (OXFD) operates in the Surgical and Medical Instrument Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.